• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺动静脉畸形患者脑并发症的风险因素:一项多中心回顾性队列研究。

Risk factors for cerebral complications in patients with pulmonary arteriovenous malformations: A multicenter retrospective cohort study.

机构信息

Department of Internal Medicine, Chonnam National University Hospital, Gwangju, Republic of Korea.

Chonnam National University Medical School, Gwangju, Republic of Korea.

出版信息

PLoS One. 2022 Dec 1;17(12):e0278610. doi: 10.1371/journal.pone.0278610. eCollection 2022.

DOI:10.1371/journal.pone.0278610
PMID:36454973
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9714939/
Abstract

OBJECTIVE

Pulmonary arteriovenous malformation (PAVM) is a rare pulmonary disease. Although most patients with PAVMs are asymptomatic, cerebral complications associated with PAVMs are often fatal. This study aimed to evaluate the risk factors for cerebral complications in patients with PAVMs.

METHODS

We retrospectively reviewed the medical charts of patients with PAVMs between 2003 and 2021 at two tertiary referral hospitals and one secondary hospital.

RESULTS

Fifty-five patients diagnosed with PAVMs were enrolled in this study. Most patients were female (89.1%), and the median age was 53 years. Thirty patients (54.5%) had incidentally detected PAVMs without symptoms. Twenty-four patients (43.7%) with PAVMs were treated with embolotherapy or surgery. Thirteen patients (23.6%) had cerebral complications. There was no significant difference in the development of cerebral complications according to treatment; however, older age (≥ 65 years) was associated with the development of new cerebral complications in untreated patients with PAVMs (odds ratio, 17.09; 95% confidence interval, 1.16-250.31; P = 0.038).

CONCLUSION

Older age (≥ 65 years) was a risk factor for the development of cerebral complications in patients with PAVMs; therefore, treatment should be considered in older patients with PAVMs.

摘要

目的

肺动静脉畸形(PAVM)是一种罕见的肺部疾病。虽然大多数 PAVM 患者无症状,但与 PAVM 相关的脑并发症通常是致命的。本研究旨在评估 PAVM 患者发生脑并发症的危险因素。

方法

我们回顾性分析了 2003 年至 2021 年间在两家三级转诊医院和一家二级医院就诊的 PAVM 患者的病历。

结果

本研究共纳入 55 例诊断为 PAVM 的患者。大多数患者为女性(89.1%),中位年龄为 53 岁。30 例(54.5%)患者无症状,偶然发现 PAVM。24 例(43.7%)患者接受了栓塞治疗或手术治疗。13 例(23.6%)患者发生了脑并发症。治疗方法与脑并发症的发生无显著差异;然而,未治疗的 PAVM 患者中年龄较大(≥65 岁)与新的脑并发症的发生相关(比值比,17.09;95%置信区间,1.16-250.31;P=0.038)。

结论

年龄较大(≥65 岁)是 PAVM 患者发生脑并发症的危险因素;因此,对于年龄较大的 PAVM 患者应考虑治疗。

相似文献

1
Risk factors for cerebral complications in patients with pulmonary arteriovenous malformations: A multicenter retrospective cohort study.肺动静脉畸形患者脑并发症的风险因素:一项多中心回顾性队列研究。
PLoS One. 2022 Dec 1;17(12):e0278610. doi: 10.1371/journal.pone.0278610. eCollection 2022.
2
Pulmonary Arteriovenous Malformations in Non-hereditary Hemorrhagic Telangiectasia Patients: An 18-Year Retrospective Study.非遗传性出血性毛细血管扩张症患者的肺动静脉畸形:一项 18 年回顾性研究。
Lung. 2020 Aug;198(4):679-686. doi: 10.1007/s00408-020-00367-w. Epub 2020 Jul 9.
3
Pulmonary arteriovenous malformations treated with embolotherapy: helical CT evaluation of long-term effectiveness after 2-21-year follow-up.经栓塞治疗的肺动静脉畸形:2至21年随访后螺旋CT对长期疗效的评估
Radiology. 2006 May;239(2):576-85. doi: 10.1148/radiol.2391050333. Epub 2006 Feb 16.
4
Clinical characteristics of pulmonary arteriovenous malformations in Koreans.韩国人肺动静脉畸形的临床特征。
Respirology. 2015 Jan;20(1):155-9. doi: 10.1111/resp.12411. Epub 2014 Oct 7.
5
Reperfusion of pulmonary arteriovenous malformations after embolotherapy.栓塞治疗后肺动静脉畸形的再灌注
J Vasc Interv Radiol. 2005 Dec;16(12):1675-83. doi: 10.1097/01.RVI.0000182163.25493.BB.
6
Embolotherapy of pulmonary arteriovenous malformations: long-term results in 112 patients.肺动静脉畸形的栓塞治疗:112例患者的长期结果
J Vasc Interv Radiol. 2004 May;15(5):451-6. doi: 10.1097/01.rvi.0000126811.05229.b6.
7
Postembolotherapy Pulmonary Arteriovenous Malformation Follow-Up: A Role for Graded Transthoracic Contrast Echocardiography Prior to High-Resolution Chest CT Scan.栓塞后肺动静脉畸形随访:高分辨率胸部 CT 扫描前分级经胸对比超声心动图的作用。
Chest. 2020 May;157(5):1278-1286. doi: 10.1016/j.chest.2019.11.023. Epub 2019 Nov 30.
8
Persistence of pulmonary arteriovenous malformations after successful embolotherapy with Amplatzer vascular plug: long-term results.使用Amplatzer血管封堵器成功栓塞治疗后肺动静脉畸形的持续存在:长期结果
Diagn Interv Radiol. 2016 Jul-Aug;22(4):358-64. doi: 10.5152/dir.2015.15262.
9
Evaluation of percutaneous transcatheter embolization for pulmonary arteriovenous malformations.经导管肺动脉瘤栓塞术治疗肺动静脉畸形的评价。
BMC Pulm Med. 2021 Mar 5;21(1):77. doi: 10.1186/s12890-021-01448-z.
10
Management of pulmonary arteriovenous malformations involves additional factors aside from the diameter of feeding arteries: a 3-year case-case retrospective analysis.肺动静脉畸形的管理除了要考虑供养动脉的直径外,还涉及其他因素:一项为期 3 年的病例对照回顾性分析。
Respir Res. 2022 Apr 30;23(1):107. doi: 10.1186/s12931-022-02030-9.

引用本文的文献

1
Neurological and cardiopulmonary manifestations of pulmonary arteriovenous malformations.肺动静脉畸形的神经和心肺表现
Front Med (Lausanne). 2024 Sep 19;11:1449496. doi: 10.3389/fmed.2024.1449496. eCollection 2024.
2
Catheter embolization for pulmonary arteriovenous malformations during chemotherapy for appendiceal adenocarcinoma: A case report of associated brain abscess.阑尾腺癌化疗期间经导管栓塞治疗肺动静脉畸形:一例合并脑脓肿的病例报告
Radiol Case Rep. 2024 Sep 4;19(11):5507-5512. doi: 10.1016/j.radcr.2024.08.066. eCollection 2024 Nov.

本文引用的文献

1
Approach to Pulmonary Arteriovenous Malformations: A Comprehensive Update.肺动静脉畸形的治疗方法:全面更新
J Clin Med. 2020 Jun 19;9(6):1927. doi: 10.3390/jcm9061927.
2
Aging and ischemic stroke.衰老与缺血性中风。
Aging (Albany NY). 2019 May 1;11(9):2542-2544. doi: 10.18632/aging.101931.
3
Hypertension and diabetes mellitus as a predictive risk factors for stroke.高血压和糖尿病作为中风的预测性风险因素。
Diabetes Metab Syndr. 2018 Jul;12(4):577-584. doi: 10.1016/j.dsx.2018.03.009. Epub 2018 Mar 19.
4
Pulmonary arteriovenous malformations: evidence of physician under-education.
ERJ Open Res. 2017 Apr 12;3(2). doi: 10.1183/23120541.00104-2016. eCollection 2017 Apr.
5
Comparison of PAVMs associated or not associated with hereditary hemorrhagic telangiectasia in the Japanese population.
Respir Investig. 2015 Nov;53(6):300-4. doi: 10.1016/j.resinv.2015.06.004. Epub 2015 Aug 20.
6
Pulmonary arteriovenous malformations.肺动静脉畸形
Am J Respir Crit Care Med. 2014 Dec 1;190(11):1217-28. doi: 10.1164/rccm.201407-1254CI.
7
Clinical characteristics of pulmonary arteriovenous malformations in Koreans.韩国人肺动静脉畸形的临床特征。
Respirology. 2015 Jan;20(1):155-9. doi: 10.1111/resp.12411. Epub 2014 Oct 7.
8
Pulmonary arteriovenous malformations and embolic complications in patients with hereditary hemorrhagic telangiectasia.遗传性出血性毛细血管扩张症患者的肺动静脉畸形和栓塞并发症
Arch Bronconeumol. 2014 Jul;50(7):301-4. doi: 10.1016/j.arbres.2013.08.006. Epub 2014 Mar 12.
9
Pulmonary arteriovenous malformation: An uncommon disease with common presentation.肺动静脉畸形:一种临床表现常见的罕见疾病。
Lung India. 2010 Oct;27(4):247-9. doi: 10.4103/0970-2113.71965.
10
Hereditary haemorrhagic telangiectasia: pathophysiology, diagnosis and treatment.遗传性出血性毛细血管扩张症:病理生理学、诊断与治疗。
Blood Rev. 2010 Nov;24(6):203-19. doi: 10.1016/j.blre.2010.07.001. Epub 2010 Sep 25.